Subscribe RSS
Client Login
  • Home
  •  
  • About CisionWire
  •  
  • Packaging & Pricing
  •  
  • Tips & Tools
  •  
  • Contact
Cision
US/Global
  • Denmark
  • Finland
  • France
  • Germany
  • US/Global
  • Norway
  • Portugal
  • Sweden
  • United Kingdom
  •  New Users  
  •  Media Members  
  •  Why CisionWire  
  • View:
  •  All news
  •  
  •  News by industry
  •  
  •  News by company
  •  
  •  Pictures
  •  
  •  Videos
Advanced search >

Press releases

MOBERG DERMA AB

Press Room
  • About
  • Press releases
    • 2010
    • 2009
    • 2008
    • 2007
  • Financial reports
  • Videos
  • Pictures
  • Subscribe by RSS
  • Contact
 
 

2007

New CEO to Strengthen Moberg Derma’s Organization 

1 Oct, 2007 14:30 CET

|

MOBERG DERMA AB

 

Media
Moberg Derma Reports Positive Phase II Results for Its K301 Product Candidate for the Treatment of Seborrheic Dermatitis 

10 Sep, 2007 10:00 CET

|

MOBERG DERMA AB

 

Media
Moberg Derma Starts Recruiting Patients for Phase III Clinical Trial for Its K101 Product Candidate to Treat Nail Fungus (Onychomycosis) 

10 Sep, 2007 10:00 CET

|

MOBERG DERMA AB

 

Media
Moberg Derma Receives Regulatory Approval to Start Clinical Phase III trial for a Novel Treatment of Nail Fungus (Onychomycosis) 

27 Jun, 2007 09:00 CET

|

MOBERG DERMA AB

 

Media
Moberg Derma Raises SEK 27,7 Million to Fund Clinical Phase III trial for a Novel Treatment of Nail Fungus (Onychomycosis) 

27 Jun, 2007 09:00 CET

|

MOBERG DERMA AB

 

Media
MOBERG DERMA AB

Subscribe by RSS

  • All information
  • Press releases
  • Financial reports
  • Pictures
  • Videos

© Cision

Terms of usage

  |  

Privacy Statement

  |  

Cookies

  |  

About Cision

  |  

Contact